Delivery Order SPE2DR25D1200-SPE2DR26FML2A
Award Date 2/5/26
Potential Completion Date 2/6/26
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $26,962.40 delivery order to Amerisourcebergen Drug Corp on February 4, 2026, for ENGERIX-B 20 MCG/ML vaccine supply, with completion by February 5, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which provides comprehensive global pharmaceutical support including vaccines, specialty medications, and medical supplies to military healthcare programs. Place of...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for ENGERIX-B 20 MCG/ML vaccine with a ceiling value of $3,033.27. The order was placed against the parent IDC with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026 supporting military healthcare programs worldwide. Place of performance is Conshohocken, Pennsylvania. The delivery order uses firm fixed...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $1,011.09 for ENGERIX-B 20 MCG/ML vaccine supply.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 6, 2026, and is priced firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency awarded a delivery order valued at $23,145.08 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.75 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine (20 micrograms per milliliter syringes). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is a child contract under...
- On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,348.12 to Amerisourcebergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with completion scheduled for January 29, 2026. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent...
- The Defense Logistics Agency awarded a $1,040.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for ENGERIX-B 20 MCG/ML vaccine supply. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a $1,080.34 delivery order to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine, with performance at the company's Conshohocken, Pennsylvania location. This non-competitive, firm fixed-price delivery order was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this order under its existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.30 to AmerisourceBergen Drug Corp for ENGERIX-B 20 MCG/ML vaccine syringes. This non-competitive, firm fixed-price delivery order, issued on December 29, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order is scheduled for completion by December 30, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of ENGERIX-B 20 MCG/ML vaccine at a ceiling value of $1,435.25. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement practices. The work is performed at AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of September 11, 2025. This delivery order is executed under...